Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
13 hedge funds and large institutions have $15.8M invested in Aptose Biosciences, Inc. in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
86% more funds holding
Funds holding: 7 → 13 (+6)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
16% less capital invested
Capital invested by funds: $18.7M → $15.8M (-$2.91M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$628K |
| 2 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$135K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$121K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$114K |
| 5 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$2.39M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$23K |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $7.65M | – | – | – |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $5.83M | -$7.25K | -3 | -0.1% |
|
|
BI
3
BVF Inc
San Francisco,
California
| $907K | – | – | – |
|
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $635K | +$628K | +260 | New |
|
|
BBA
5
Baker Bros. Advisors
New York
| $181K | -$2.39M | -991 | -93% |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $137K | +$114K | +47 | +522% |
|
|
WMSA
7
Weiss Multi-Strategy Advisers
New York
| $136K | +$135K | +56 | New |
|
|
DCM
8
DAFNA Capital Management
Los Angeles,
California
| $121K | +$121K | +50 | New |
|
|
KCM
9
Knoll Capital Management
Miami,
Florida
| $108K | +$106K | +44 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $44K | +$14.5K | +6 | +50% |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $22K | +$21.7K | +9 | New |
|
12
Bank of America
Charlotte,
North Carolina
| $4K | +$4.83K | +2 | New |
|
13
Morgan Stanley
New York
| $3K | +$2.42K | +1 | New |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$23K | -8 | Closed |
|
APTO Hedge Fund Activity: Q1 2015 in Review
13 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q1 2015, worth a combined $15.8M — down 16% from $18.7M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new APTO positions and 1 closed out — a net gain of 6 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $628K. The largest seller was Baker Bros. Advisors, cutting an estimated $2.39M.
- 13 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q1 2015, up from 7 in Q4 2014.
- Funds reported $15.8M of Aptose Biosciences, Inc. stock for Q1 2015, down 16% quarter-over-quarter.
- 7 funds opened new Aptose Biosciences, Inc. positions in Q1 2015 and 1 closed out, a net change of +6 holders.
- The largest Aptose Biosciences, Inc. buyer in Q1 2015 was Bank of Montreal, an estimated $628K added.
- The largest Aptose Biosciences, Inc. seller in Q1 2015 was Baker Bros. Advisors, an estimated $2.39M sold.
Based on aggregated 13F filings for Q1 2015.